Cargando…
Regulation of osteoclast function and bone mass by RAGE
The receptor for advanced glycation end products (RAGE) is a member of the immunoglobulin superfamily that has multiple ligands and is implicated in the pathogenesis of various diseases, including diabetic complications, neurodegenerative disorders, and inflammatory responses. However, the role of R...
Autores principales: | Zhou, Zheng, Immel, David, Xi, Cai-Xia, Bierhaus, Angelika, Feng, Xu, Mei, Lin, Nawroth, Peter, Stern, David M., Xiong, Wen-Cheng |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2118287/ https://www.ncbi.nlm.nih.gov/pubmed/16606672 http://dx.doi.org/10.1084/jem.20051947 |
Ejemplares similares
-
Soluble RAGE but not endogenous secretory RAGE is associated with albuminuria in patients with type 2 diabetes
por: Humpert, Per M, et al.
Publicado: (2007) -
The Complexity of Sporadic Alzheimer's Disease Pathogenesis: The Role of RAGE as Therapeutic Target to Promote Neuroprotection by Inhibiting Neurovascular Dysfunction
por: Perrone, Lorena, et al.
Publicado: (2012) -
Bench-to-bedside review: The inflammation-perpetuating pattern-recognition receptor RAGE as a therapeutic target in sepsis
por: Bopp, Christian, et al.
Publicado: (2008) -
Receptor for advanced glycation endproducts (RAGE) deficiency protects against MPTP toxicity
por: Teismann, Peter, et al.
Publicado: (2012) -
RAGE signaling sustains inflammation and promotes tumor development
por: Gebhardt, Christoffer, et al.
Publicado: (2008)